Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Free Cash Flow (2010 - 2026)

Palatin Technologies' (PTN) quarterly Free Cash Flow came in at -$4.5 million in Q1 2026, up 16.79% YoY from -$3.8 million in Q1 2025, and up 7.31% on a QoQ basis from -$4.8 million in Q4 2025.

Palatin Technologies (PTN) Free Cash Flow (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Free Cash Flow data on file, last reported at -$4.5 million in Q1 2026.

  • Quarterly Free Cash Flow rose 16.79% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.0 million (up 36.82% YoY) and the FY2025 annual result came in at -$21.3 million, up 32.37% from the prior year.
  • Free Cash Flow advanced to -$4.5 million in Q1 2026, from -$4.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.5 million in Q1 2023 to a low of -$10.5 million in Q4 2023.
  • A 5-year average of -$6.5 million and a median of -$6.5 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 3253.32% — and 2023, when it surged 84.06%.
  • Tracing PTN's Free Cash Flow over 5 years: stood at -$9.8 million in 2022, then declined by 7.29% to -$10.5 million in 2023, then soared by 53.9% to -$4.8 million in 2024, then rose by 0.83% to -$4.8 million in 2025, then grew by 7.31% to -$4.5 million in 2026.
  • The last three Free Cash Flow figures came in at -$4.5 million (Q1 2026), -$4.8 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Palatin Technologies 40.37 Mn 40.37 Mn - -4.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.46 Mn
Mar 31, 2026 -4.46 Mn
Dec 31, 2025 -4.81 Mn
Dec 31, 2025 -4.81 Mn
Sep 30, 2025 -1.62 Mn
Sep 30, 2025 -1.62 Mn
Jun 30, 2025 -4.09 Mn
Jun 30, 2025 -4.09 Mn
Mar 31, 2025 -5.35 Mn
Mar 31, 2025 -5.35 Mn
Dec 31, 2024 -4.85 Mn
Dec 31, 2024 -4.85 Mn
Sep 30, 2024 -7.02 Mn
Sep 30, 2024 -7.02 Mn
Jun 30, 2024 -6.48 Mn
Jun 30, 2024 -6.48 Mn
Mar 31, 2024 -8.61 Mn
Mar 31, 2024 -8.61 Mn
Dec 31, 2023 -10.51 Mn
Dec 31, 2023 -10.51 Mn